Related Funds
| Fund Name | Location |
| Divergence Ventures | - |
| Dquadrat Equity Partner | - |
| Efficiency | Alicante, Comunidad Valenciana, Spain |
| EXOR N.V. | Amsterdam, Noord-Holland, The Netherlands |
| Gaea Technology | China, Guangdong, Shenzhen |
| Gains Associates | France, Ile-de-France, Paris |
| Jiatai Yongli Investment Management | Beijing, Beijing, China |
| Jike Xueyuan | Beijing, Beijing, China |
| NES Partners | Copenhagen, Denmark, Hovedstaden |
| NewDo Venture | California, Palo Alto, United States |
| Panacea Venture | Cayman Islands, Grand Cayman |
| Samch Capital | China, Shanghai |
| SpringBank TechVentures | Alberta, Calgary, Canada |
| Sud Rhone-Alpes Capital | France, Grenoble, Rhone-Alpes |
| Toyoda Gosei | Aichi Prefecture, Japan, Kiyosu |
| Wobbly-Door Ventures | California, Palo Alto, United States |
| Zi Mei She | China, Guangdong, Shenzhen |
| Zillionize Angel | California, Palo Alto, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Macrowing | 02 Mar 2023 | Shanghai, Shanghai, China | |||
Zhenge Biotech | $15M | 18 Aug 2022 | Shanghai, China | ||
Xingmai Technology | $15M | 02 Aug 2022 | Changning, Shanghai, China | ||
Hinova Pharma | $154M | 06 Oct 2020 | Qingyang District, Sichuan, China | ||
MicuRx Pharmaceuticals | $46M | 05 Aug 2020 | Hayward, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Macrowing | 02 Mar 2023 | Shanghai, Shanghai, China | |||
Zhenge Biotech | $15M | 18 Aug 2022 | Shanghai, China | ||
Xingmai Technology | $15M | 02 Aug 2022 | Changning, Shanghai, China | ||
Hinova Pharma | $154M | 06 Oct 2020 | Qingyang District, Sichuan, China | ||
MicuRx Pharmaceuticals | $46M | 05 Aug 2020 | Hayward, California, United States |
Get matched with relevant funds
